CA2053272A1 - Device for administering an active agent to the skin or mucosa - Google Patents

Device for administering an active agent to the skin or mucosa

Info

Publication number
CA2053272A1
CA2053272A1 CA2053272A CA2053272A CA2053272A1 CA 2053272 A1 CA2053272 A1 CA 2053272A1 CA 2053272 A CA2053272 A CA 2053272A CA 2053272 A CA2053272 A CA 2053272A CA 2053272 A1 CA2053272 A1 CA 2053272A1
Authority
CA
Canada
Prior art keywords
membrane
layer
backing
peelable
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2053272A
Other languages
French (fr)
Other versions
CA2053272C (en
Inventor
Yunik Chang
Dinesh C. Patel
Charles D. Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23272639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2053272(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2053272A1 publication Critical patent/CA2053272A1/en
Application granted granted Critical
Publication of CA2053272C publication Critical patent/CA2053272C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Abstract

A transdermal drug delivery device comprising a drug formulation-containing reservoir defined by a backing layer and a drug-permeable membrane layer, a peelable inner liner that underlies the reservoir and a portion of the backing/membrane outwardly of the reservoir periphery, an adhesive layer that underlies the inner liner and outwardly extending portions of the membrane/backing layers, and a peelable release liner layer that underlies the adhesive layer with a first permanent heat seal between the backing and the membrane about the perimeter of the reservoir and another concentric peelable (impermanent) heat seal between the membrane and the inner liner positioned underlying and at a radius not less than the first permanent heat seal, the heat seals and peelable barrier layer providing barriers that isolate the drug formulation from the adhesive.
CA002053272A 1989-03-21 1990-03-21 Device for administering an active agent to the skin or mucosa Expired - Lifetime CA2053272C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/326,536 US4983395A (en) 1987-11-12 1989-03-21 Device for administering an active agent to the skin or mucosa
US326,536 1989-03-21

Publications (2)

Publication Number Publication Date
CA2053272A1 true CA2053272A1 (en) 1990-09-22
CA2053272C CA2053272C (en) 1998-05-19

Family

ID=23272639

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002053272A Expired - Lifetime CA2053272C (en) 1989-03-21 1990-03-21 Device for administering an active agent to the skin or mucosa

Country Status (12)

Country Link
US (1) US4983395A (en)
EP (1) EP0464106B1 (en)
JP (1) JPH0818976B2 (en)
KR (1) KR0149492B1 (en)
AT (1) ATE154751T1 (en)
AU (1) AU631417B2 (en)
CA (1) CA2053272C (en)
DE (1) DE69030974T2 (en)
DK (1) DK0464106T3 (en)
ES (1) ES2103271T3 (en)
HK (1) HK1003322A1 (en)
WO (1) WO1990011065A1 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5484604A (en) * 1990-07-21 1996-01-16 Chatfield Pharmaceuticals Limited Cross-linked alginate transdermal medicine delivery devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
AU646453B2 (en) * 1991-04-26 1994-02-24 Astra Aktiebolag Topical dressings
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
WO1994022432A1 (en) * 1993-04-07 1994-10-13 Rexham Industries Corp. Method of coating microporous membranes and resulting products
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
DK0797988T3 (en) 1993-07-19 2009-05-11 Univ British Columbia Anti-angiogenic compositions and methods for their use
DE4341444C2 (en) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Active substance-containing plaster and process for its production
US5656279A (en) * 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
WO1996019205A1 (en) * 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5759560A (en) * 1995-07-27 1998-06-02 Bio Med Sciences, Inc. Silicone thermoplastic sheeting for scar treatment and useful article thereof; process of manufacture and use
US5733571A (en) * 1995-12-08 1998-03-31 Euro-Celtique, S.A. Transdermal patch for comparative evaluations
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
JP2001503062A (en) * 1996-10-30 2001-03-06 セラテック・インコーポレーテッド Salts of fatty acid esters of lactic acid as permeation enhancers
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DK1031347T3 (en) 1999-01-27 2002-07-08 Idea Ag Transnasal transport / immunization with highly customizable carriers
ATE216875T1 (en) 1999-01-27 2002-05-15 Idea Ag NON-INVASIVE VACCINATION THROUGH THE SKIN
WO2000054755A1 (en) * 1999-03-17 2000-09-21 Barbara Sheila Goldberg An adhesive dispensing arrangement
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
MXPA01012769A (en) * 1999-06-11 2003-06-24 Watson Pharmaceuticals Inc Administration of non-oral androgenic steroids to women.
MXPA02000053A (en) * 1999-07-05 2003-07-21 Idea Ag A method for the improvement of transport across adaptable semi-permeable barriers.
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
CA2389865A1 (en) * 1999-11-04 2001-05-10 Xel Herbaceuticals Transdermal administration of huperzine
US20050042271A1 (en) * 1999-11-19 2005-02-24 Xel Herbaceuticals, Inc . Transdermal delivery system for alkaloids of aconitum species
US6896898B1 (en) 1999-11-19 2005-05-24 Xel Herbaceuticals, Inc. Transdermal delivery system for alkaloids of aconitum species
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
FR2822711B1 (en) 2001-03-28 2003-06-13 Oreal TREATMENT DEVICE COMPRISING AN ENVELOPE DEFINING A CAVITY IN WHICH A PART OF THE BODY MAY BE ENGAGED
KR100438254B1 (en) * 2001-03-29 2004-07-02 아이큐어 주식회사 Matrix form of preparation for transdermal administration of vitamin d analog
ATE438418T1 (en) 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical HYDROGEL COMPOSITIONS
US6803420B2 (en) * 2001-05-01 2004-10-12 Corium International Two-phase, water-absorbent bioadhesive composition
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050163829A1 (en) * 2001-12-07 2005-07-28 Norbert Hoenzelaer Device and patch for controlled release of vanillin
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
CA2729967C (en) * 2002-12-13 2018-01-16 Schering-Plough Healthcare Products, Inc. Use of a transdermal or transmucosal ingredient delivery device
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
WO2005025549A2 (en) * 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
CN103497713B (en) * 2004-08-05 2018-07-17 考里安国际公司 Adhesive composition
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
US20080095722A1 (en) * 2004-11-12 2008-04-24 Idea Ag Extended Surface Aggregates in the Treatment of Skin Conditions
DK1895994T3 (en) * 2005-05-13 2010-12-20 Alza Corp Multilayer drug delivery system with barrier against reservoir material flow
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US10137135B2 (en) * 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US7955677B2 (en) * 2005-12-07 2011-06-07 Mylan Technologies, Inc. Two-sided non-stick release film
PE20081140A1 (en) * 2006-10-25 2008-09-22 Amgen Inc THERAPEUTIC AGENTS BASED ON PEPTIDES DERIVED FROM TOXINS
MX2009012609A (en) 2007-05-22 2009-12-07 Amgen Inc Compositions and methods for producing bioactive fusion proteins.
NZ582565A (en) 2007-07-10 2012-07-27 Agile Therapeutics Inc Dermal delivery device with in situ seal
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
US8629184B2 (en) 2008-09-27 2014-01-14 TARAXOS, Inc. Topical formulations for treatment of neuropathy
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
CN103930437A (en) 2011-03-16 2014-07-16 安姆根有限公司 Potent and selective inhibitors of Nav1.3 and Nav1.7
WO2013053480A1 (en) 2011-10-11 2013-04-18 Secutech International Pte. Ltd. Composition for introducing nucleic acids into cells
US9656051B2 (en) 2011-12-01 2017-05-23 Avery Dennison Retail Information Services, Llc Devices with selectively permeable barriers
JP6114841B2 (en) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． Glycopyrrolate salt
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
UY35397A (en) 2013-03-12 2014-10-31 Amgen Inc POWERFUL AND SELECTIVE INHIBITORS OF NaV1.7
WO2015089310A1 (en) * 2013-12-11 2015-06-18 Atkinson Oscar Occlusive skin covering
CN110475548A (en) 2016-12-29 2019-11-19 纯比率控股股份有限公司 Modularization transdermal delivery system and related preparation and application
US11318190B2 (en) 2017-05-05 2022-05-03 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating liver disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (en) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd Base material composition and medicinal composition for external use
US4696821A (en) * 1983-10-11 1987-09-29 Warner-Lambert Company Transdermal delivery system for administration of nitroglycerin
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
ES8608895A1 (en) * 1984-08-17 1986-07-16 Allpack Ind Lohnverpackung Therapeutical adhesive plaster and process for its manufacture.
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
JPH0744940B2 (en) * 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa

Also Published As

Publication number Publication date
AU5341690A (en) 1990-10-22
US4983395A (en) 1991-01-08
KR920700019A (en) 1992-02-19
AU631417B2 (en) 1992-11-26
DE69030974T2 (en) 1997-12-18
JPH04506062A (en) 1992-10-22
HK1003322A1 (en) 1998-10-23
DK0464106T3 (en) 1997-07-21
JPH0818976B2 (en) 1996-02-28
KR0149492B1 (en) 1998-10-01
ATE154751T1 (en) 1997-07-15
EP0464106A4 (en) 1993-09-22
EP0464106A1 (en) 1992-01-08
DE69030974D1 (en) 1997-07-31
CA2053272C (en) 1998-05-19
EP0464106B1 (en) 1997-06-25
ES2103271T3 (en) 1997-09-16
WO1990011065A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
CA2053272A1 (en) Device for administering an active agent to the skin or mucosa
AU2467788A (en) Device for administering an active agent to the skin or mucosa
JP3023989B2 (en) Topical dressing, method of manufacturing topical dressing and use of topical dressing
CA1261702A (en) Therapeutic device for the administration of medicaments
US4822617A (en) Drug delivery device
AU3268689A (en) Transdermal monolith systems
JP4388068B2 (en) Transdermal patch comprising an active agent transfer barrier layer
GB8512358D0 (en) Transdermal delivery system
MX9603667A (en) Drug-containing adhesive composite transdermal delivery device.
WO2000033812A3 (en) Transdermal patch for delivering volatile liquid drugs
WO1997020582A3 (en) Transdermal patch for comparative evaluations
MX9704291A (en) Transdermal delivery system with adhesive overlay and peel seal disc.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry